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Hodgkin’s lymphoma with multifocal 
Staphylococcus aureus infection  
in a 29-year-old male — a case study
ABSTRACT
Hodgkin’s lymphoma (HL) is a neoplastic disease of the lymphoid tissue. It is characterised by the presence of 
B lymphocyte-derived monoclonal Reed-Sternberg and Hodgkin cells, which tend to create a massive inflam-
mation reaction in lymph nodes. Lymphadenopathy is common. The prognosis depends on the clinical stage 
according to Ann Arbor (Cotswold’s modification) classification and unfavourable prognostic factors. The ABVD 
chemotherapy regimen is the gold standard of treatment for patients with HL. This case report presents a patient 
diagnosed and treated for neck presentation of Hodgkin’s lymphoma intricate sepsis and coxarthritis because of 
Staphylococcus aureus infection. The treatment was arthrotomy. After the patient’s recovery chemotherapy was 
continued and complete remission was achieved.
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Introduction
Hodgkin’s lymphoma (HL) is a malignancy of lym-
phoid tissue. It is characterised by the presence of B 
lymphocyte-derived monoclonal Reed-Sternberg cells 
and Hodgkin’s cells, which induce a massive reaction 
of normal lymphocytes in the lymph nodes. Therefore, 
lymphadenopathy is a common clinical manifestation. 
In the microscopic image of affected lymph node, 
reactive cells predominate and cancerous cells consti-
tute a minority — around 2% [1, 2]. The incidence of 
Hodgkin’s lymphoma is constant, whilst the course of 
morbidity curve is bimodal, with two peaks at the age of 
25–30 and 50–55 years [3]. In 2010, over 700 new cases 
were reported in Poland [3].
The prognosis in patients with HL depends on clinical 
stage (CS) of disease assessed according to the Ann Arbor 
classification and the presence of unfavourable prognostic 
factors [4, 5]. The ABVD chemotherapy regimen is the 
gold standard of the treatment for patients with HL [6]. In 
special cases, due to vital indications, such as: extremely 
rapid disease dynamics, superior vena cava syndrome 
(SVCS), compression of the spinal cord, compression of 
the airways with dyspnoea, or ureteral closure, it may be 
necessary to initiate the treatment before the diagnosis 
is completed [5]. All issues that cause delayed diagnosis, 
as well as implementation and continuation of optimal 
therapy, reduce the patient’s chances to be cured. This 
paper describes a case of a patient of the Oncology De-
partment with the Haematology Subdivision of Provincial 
Specialist Hospital No. 3 in Rybnik — a 29-year-old man 
diagnosed and treated for tumours and neck phlegmon 
with subsequent diagnosis of HL, complicated by acute 
respiratory failure, purulent infections of soft tissues, and 
blood-borne hip arthritis with septic shock in the course 
of Staphylococcus aureus infection.
Case report
According to an interview in January 2013, 
a 29-year-old man noticed clinical symptoms in the 
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form of a neck tumour located in the middle part and 
then covering the left side of the neck. In March 2013, 
the patient visited a family doctor who ordered an anti-
biotic — amoxicillin with clavulanic acid administered 
orally. Therapy did not bring the expected improvement. 
The patient observed intensification of the inflammatory 
process with the progression of infiltration to the chest 
and the formation of purulent fistula. The patient was 
admitted to the ENT department. A neck phlegmon 
penetrating into the mediastinum was diagnosed and an-
tibiotic therapy with ceftriaxone and metronidazole was 
introduced. In a computed tomography (CT) examina-
tion of the neck and chest, a neck abscess penetrating 
into the mediastinum and cervical lymphadenopathy 
with compression and modelling of the trachea 
were described. The lesions raised the suspicion of 
a proliferative disease of the lymphatic system with 
secondary purulent lesions. The patient was referred 
for further treatment to the chest surgery clinic, 
where the neck and mediastinum were drained, and 
antibiotic therapy was continued according to the 
culture (imipenem). Then a mediastinoscopy was 
performed with a biopsy. The histopathological 
report described: “Neoplasma malignum probabiliter 
lymphogenes. Due to the small amount of material 
available for immunohistochemistry (predominant 
necrotic masses), its execution was abandoned, with 
a recommendation to carry it out in the oncological 
centre”. The patient was advised to continue treat-
ment in the oncology centre, and a consultation date 
was agreed.
On May 24, 2013 (before the date of consultation in 
the oncology centre), the patient was admitted to the 
Hospital Emergency Department of Provincial Special-
istic Hospital No. 3 in Rybnik in a severe condition with 
symptoms of acute respiratory failure and SVCS. The 
patient was intubated, and a CT scan was performed 
(Fig. 1, 2) in which the airway pressure was visualised. 
The patient was admitted to the Intensive Care Unit 
(ICU), where sedation and mechanical ventilation were 
used. Due to the pressure of tumour masses on the res-
piratory tract, leading to respiratory failure, a decision 
was made to introduce antineoplastic treatment. In the 
initial histopathological examination, cancer originat-
ing from the lymphatic system was diagnosed. At the 
time of making the decision to start treatment with vital 
indications, there was no more precise diagnosis. High 
dynamics of the disease suggested aggressive lymphoma, 
as in diffuse large B-cell lymphoma (DLBCL). Based 
on these clinical data, the patient was qualified for 
CHOP chemotherapy.
In ICU the patient received one cycle of CHOP 
rescue chemotherapy (cyclophosphamide, doxorubicin, 
vincristine, prednisone). Reduction in the swelling of 
neck tissues was achieved. The patient was disconnected 
Figure 1. Computed tomography of the neck and chest before 
treatment. Extensive hypodense structures in the neck and 
mediastinum over a length of about 20 cm. The maximum cross-
section of changes in the neck and mediastinum — 10 × 7.5 cm
Figure 2. Computed tomography of the neck and chest 
before treatment. Larynx, thyroid, and oesophagus 
structures are compressed and displaced towards the right 
side; trachea modelled, compressed, with endotracheal 
tube in the lumen
from the ventilator and extubated. In order to protect 
the airway obstruction, a tracheostomy was performed.
After improving the general condition, the patient 
was transferred to the Oncology Department. At ad-
mission, the patient was in good performance status 
according to the ECOG (Eastern Cooperative Oncology 
Group) scale, scoring 2. During the stay, the second 
CHOP cycle was administered. In order to establish the 
diagnosis, histopathological verification and immunohis-
tochemical examination were ordered. After the second 
cycle, the patient was discharged home.
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Between the cycles, the patient was hospitalised in 
the Department of Internal Diseases due to inflamma-
tory infiltration of both forearms with the formation 
of left forearm abscess in the course of staphylococcus 
infection, where antibiotic therapy according to the 
antibiogram was continued until the symptoms resolved 
(ciprofloxacin was administered parenterally).
During the next, third cycle of chemotherapy a veri-
fied histopathological diagnosis was given: “Classical 
Hodgkin’s lymphoma [CD30(+), CD15(+), MUM1(+), 
CD20(–), CD3(–)]. Extensive necrotic changes present 
in the material make it impossible to determine the sub-
type”. In order to determine the current clinical stage of 
the disease, imaging examinations were performed (Fig. 
3–5), in which the reduction of infiltrative lesions was 
confirmed. Establishing the initial stage was very difficult 
because the patient started treatment in an ICU, without 
full diagnosis, and with no bone marrow trepanobiopsy 
or positron emission tomography (PET). On the basis 
of imaging (CT) and laboratory tests performed at the 
ICU, the disease clinical stage was assessed as IIB with 
the presence of unfavourable prognostic factors. In 
medical history the patient reported a decrease in body 
weight and recurrent fevers, so it was considered that 
general symptoms were also present. The patient was 
qualified for 6–8 cycles of ABVD chemotherapy fol-
lowed by involved-field radiotherapy (IF-RT) at a dose 
of 20–36 Gy for residual or primary tumour [6]. ABVD 
chemotherapy was started. Due to the presence of ad-
ditional risk factors for febrile neutropaenia (FN), such 
as advanced disease and poor general condition, the 
patient was qualified for FN primary prevention using 
short-acting granulocyte colony-stimulating factors 
(G-CSF). The patient continued chemotherapy in a good 
general condition, without significant complications.
On August 23, 2013, the patient was admitted for the 
fourth cycle of ABVD chemotherapy in severe general 
condition; ECOG performance status was defined as 
3/4. The patient was lying due to the pain of the sa-
cral and lumbar spine regions and lower limbs. In the 
physical examination the following were seen: forced 
abduction of lower limb, severe groin and right thigh 
pain, and right limb paresis with normal blood supply 
and innervation. The patient was suffering a lot despite 
intensive treatment — his pain intensity on the Numeri-
cal Rating Scale (NRS) was determined as 10. Labora-
tory tests revealed increased inflammation parameters 
(C-reactive protein [CRP] — 216.56 mg/L, erythrocyte 
sedimentation rate [ESR] — 110 mm/h).
A CT scan was performed in which the features 
of the right hip joint damage were shown (Fig. 6, 7). 
Based on clinical status and imaging examinations, 
haematogenous (blood-borne) hip arthritis was diag-
nosed. Broad-spectrum intravenous antibiotics were 
introduced: vancomycin at a dose of 1 g every 12 hours 
and cloxacillin 500 mg every 6 hours.
Figure 3. Computed tomography of the neck and chest before 
treatment. From the back the structure of infiltration reaches 
the paraspinal region with the width from approx. 7 cm 
Figure 4. Computed tomography of the neck and chest after 
2 cycles of chemotherapy. Currently, the pathological structure in the 
mediastinum and neck is much smaller than in the previous study
Figure 5. Computed tomography of the neck and chest after 
2 cycles of chemotherapy. The largest dimensions of the lesion 
are 63 × 40 mm 
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Figure 6. Computed tomography of the chest, abdomen, and 
pelvis; right hip joint. Interruption of the cortical layer of the 
femoral head
Figure 7. Computed tomography of the chest, abdomen, and pelvis; 
right hip joint. Around the head of the right femur, pathological 
structures with densities up to 30 UH (liquid-fluid) visible between 
the tense capsule and the outlines of the cortical bone layer
According to the Gaechter and Stutz classification 
of joint inflammations, stage IV arthritis was diagnosed 
with infiltration and undermining of cartilage as well 
as radiological signs of subchondral osteolysis and ero-
sions [7, 8] (Fig. 6, 7). According to the algorithm for 
the management of infectious arthritis in the case of 
cartilage destruction, the joint should be resected and 
a limp joint should be formed [7–9]. The patient was 
transferred to the Orthopaedic Department, where 
the capsule, head, and femoral neck were removed 
(Girdlestone procedure). Staphylococcus aureus was 
isolated by a pus culture. In the postoperative period, 
the patient was respiratorily insufficient with symptoms 
of septic shock. The patient was transferred again to the 
ICU, where artificial ventilation, continuous haemo-
filtration, intensive antibiotic therapy, and circulatory 
support were used. After normalisation of inflammatory 
parameters and creatinine concentration and improve-
ment of his general condition the patient was transferred 
to the Department of Oncology, where the ABVD 
chemotherapy was continued. In the CT scan after the 
fourth ABVD cycle, a reduction in lesions meeting stable 
disease (SD) criteria according to RECIST (Response 
Evaluation Criteria in Solid Tumours) 1.1 was described. 
A continuation of the treatment was ordered; however, 
due to the suspicion of knee arthritis during the next 
stay, the therapy was completed at this stage. The knee 
joint puncture did not confirm the bacterial aetiology. 
The patient underwent partial oral sanation with the 
extraction of affected teeth. In a PET CT examina-
tion performed after eight administration of ABVD 
chemotherapy (four full cycles) and two CHOP admini-
strations, no active disease features were described. 
The patient was referred to the Department of Radio-
therapy. An important element of further therapy was 
rehabilitation, to improve the functionality of patients 
with so-called hanging hip and provide him with the 
highest level of independence. Subsequently, the patient 
did not report for scheduled follow-up visits. Based on 
the hospital records, the patient was determined to die 
in 2017 due to alcoholic liver failure and bleeding from 
oesophageal varices.
Discussion
According to the current guidelines, patients with 
advanced HL with clinical stage IIB and the presence 
of poor prognosis factors should receive 6–8 cycles of 
ABVD chemotherapy followed by IF-RT at 20–36 Gy 
for residual or primary tumour [6]. However, due to the 
delay of proper diagnosis and purulent lesions causing 
numerous and dangerous complications during the 
treatment the management in the presented case was 
significantly impeded. Delaying the proper diagnosis 
may not only reduce the chances of the patient being 
cured, but also pose an immediate threat to life, as in the 
case described, due to acute respiratory failure.
The time period from the collection of material for 
histopathological verification and immunohistochemi-
cal studies was two months. The purulent lesions with 
a staphylococcal aetiology occurring in the patient 
complicated and confused the picture of the underlying 
disease. After surgical treatment and targeted antibiotic 
therapy, they retreated and appeared in a different loca-
tion. There are available in medical literature the case 
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reports of HL symptoms, especially the nodular sclerosis 
form with abscesses of various locations: abscess in the 
chest wall, liver, lung, spleen, axillary region, or pancreas 
[10–15]. The cultures of such abscesses were mostly 
aseptic, which indicated their non-infectious aetiology 
and should suggest the widening of the diagnosis. Such 
an unusual manifestation of the disease made diagnosis 
difficult, also due to the problem of obtaining material 
for histopathological examination; this contributed to 
therapeutic failures [15].
In the presented case, purulent lesions were asso-
ciated with staphylococcal infection. The co-incidence 
of HL and Staphylococcus aureus infections are rare. 
Immunity disorders typical for HL are associated with 
decreased capacity of lymphoid dendritic cells (plas-
macytoid dendritic cells — s-pDCs) to produce inter-
feron-a (IFN-a) and a reduced number of circulating 
CD4 + T cells [16]. These disorders mainly cause weak-
ness of cellular immunity and contribute to systemic, 
opportunistic viral, fungal, protozoan, or tuberculous 
infections [16–22]. The spectrum of infections occurring 
in patients with HL is similar to other immune disorders 
such as acquired immunodeficiency syndrome (AIDS), 
glucocorticoid therapy, severe combined immunodefi-
ciency syndrome (SCID), or Di George syndrome [16]. 
In the case of bacterial infections in HL, causing serious 
infections confirmed in a microbiological study, Strep-
tococcus pneumoniae is a common aetiological factor 
[19]. Coexistence of Staphylococcus aureus infection 
and HL is extremely rare [23]. The only description of 
wrist bone osteomyelitis of staphylococcal aetiology in 
a patient with HL is available in the literature [23]. Bone 
infections with other aetiologies are also described. In 
presented cases of bone and marrow infections (os-
teomyelitis), the infection was caused by bloodstream, 
usually due to a wound or soft tissue damage [22–24].
According to a study by Raluca-Ana Rus, published 
in the “Journal of Research in Medical Sciences” in 2018, 
concerning infections associated with chemotherapy 
in patients treated for haematological malignancies, in 
34.4% of HL patients infectious complications were 
observed, among them 21.9% were bacterial infections, 
9.4% — fungal, 3.1% — viral, while in the remaining 
6.3% no aetiology was established [25]. The most common 
bacterial infection in patients with HL observed during 
chemotherapy was Clostridium difficile infection [25].
Purulent, blood-borne hip infection in adults is very 
rare [8, 10, 11, 26–28]. The correct diagnosis is extremely 
important because of the serious consequences of the 
disease [26–30]. According to the literature, the risk 
of Staphylococcus aureus infection increases in cases 
of tissues disruption, the presence of a foreign body 
in tissues, or comorbidities, such as: cancer, metabolic 
diseases, and immunosuppressive or anticancer therapy 
[24, 26, 27]. The main risk factors of staphylococcal bone 
infections are coexistent tissue blood supply disorders 
(e.g. in course of diabetes or vascular disease), high 
clinical stage of the cancer (e.g. HL with the presence 
of bone lesions — stage IV), and bone growth period 
when the bone is more susceptible to infection — hence 
osteoarthritis is more common in children. Anticancer 
treatment, such as chemo- and radiotherapy, is an addi-
tional risk factor [24, 25, 29, 30]. In the presented case, 
bone inflammation was probably blood-borne and was 
a consequence of changes either in the skin and soft 
tissues or teeth and could be associated with the che-
motherapy used, as well as the presence of a malignant 
tumour and its advanced clinical stage.
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